NeuroPace Inc

NPCE Nasdaq CIK: 0001528287

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 455 N. BERNARDO AVENUE, MOUNTAIN VIEW, CA, 94043
Mailing Address 455 N. BERNARDO AVENUE, MOUNTAIN VIEW, CA, 94043
Phone 6502372700
Fiscal Year End 1231
EIN 223550230

Financial Overview

FY2025

-$21.46M
Net Income
$86.63M
Total Liabilities

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report March 25, 2026 View on SEC
4 Insider stock transaction report March 24, 2026 View on SEC
4 Insider stock transaction report March 24, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
10-K Annual financial report March 3, 2026 View on SEC
8-K Current report of material events March 3, 2026 View on SEC
4 Insider stock transaction report March 2, 2026 View on SEC

Annual Reports

10-K March 3, 2026
  • Achieved strong 22% year-over-year revenue growth, reaching $65.4 million in 2025.
  • Maintained a healthy gross margin of 70.5%, indicating strong product profitability potential.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.